Background: We evaluated the morbidity and mortality after anatomical hepatectomy with the glissonean pedicle approach, and attempted to clarify whether there might be differences in long-term outcomes in relation to the morbidity in patients with hepatocellular carcinoma (HCC). Methods: Anatomical hepatectomy with the glissonean pedicle approach was developed in 1984. 1953 patients with HCC underwent various anatomical hepatectomies between 1985 and 2014. The morbidity (Clavien-Dindo class IIIa or more) and mortality (30-day and 90-day) were evaluated among six 5-year eras (1985-1989, 1990-1994, 1995-1999, 2000-2004, 2005-2009, 2010-2014). Results: 460 patients (24%) showed morbidity after hepatectomy. The overall 30-day and 90-day mortality rates were 1.7% and 3.6%, respectively. Blood loss >2L (45%, 34%, 33%, 17%, 14%, 8%: p< 0.0001) and bile leakage (29%, 15%, 19%, 11%, 13%, 7%: p< 0.0001), and morbidity (41%, 23%, 28%, 17%, 20%, 14%: p< 0.0001) were decreased gradually over the eras. 30-day (3.9%, 3.0%, 1.8%, 1.3%, 0.3%, 0.5%: p=0.0074) and 90-day mortality (7.8%, 4.3%, 3.8%, 2.8%, 2.2%, 1.4%: p=0.0036) were significantly improved over the eras. Blood loss >2L (p= 0.0244) was an independent risk factor for 30-day mortality, and blood loss >2L (p=0.0271) and bile leakage (p=0.0078) were independent risk factors for 90-day mortality on multivariate analysis. Bile leakage (p=0.004) and morbidity (p< 0.0001) were significant independent prognostic factors for overall survival in patients with HCC. Conclusions: Anatomical hepatectomy with the glissonean pedicle approach was achieved safely in patients with HCC. For more safety and longer survival, blood loss, bile leakage, and morbidity should be reduced.
Read full abstract